Rentabilitas dodolan miturut bathi resik NextCure (NXTC)

Tandha merek NextCure, Inc. (NXTC)

NextCure, Inc. (NXTC) protects its business through unique patents and strict FDA regulations. As a non-cyclical biotech, the company relies on clinical trial results rather than GDP. The development of antibodies to combat tumor resistance diversifies its risks. Net income per unit of sales, as shown by the indicator trend on the GURU.Markets chart, reflects a trajectory where the metric has reached the 0.00 level, helping investors avoid purchasing an overpriced asset.

NXTC: Rentabilitas resik perusahaan NextCure Corporation 04.07.2022 - 19.11.2026

Rincian analitis perusahaan NextCure, Inc.

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:nextcure.com - NXTC
Barang unggulan NextCure Corp

NextCure, Inc. (NXTC) focuses on the early stages of immuno-oncology drug development. This metric is calculated as the ratio of net income to revenue, measuring the efficiency of converting revenue into final capital. For the investor, this metric serves as an indicator of business resilience to inflationary shocks and rising interest rates. Given the binary risks of the pipeline, a lean operating model smooths out volatility. By analyzing the net margin of commercial and production activities, one can assess the company's speed of adaptation to external crises.

Analisis pesaing

NantKwest (IBRX) - Margin resik|Margin resik Immunocore PLC (IMCR)|Rentabilitas dodolan miturut bathi resik JANX|RCUS - Tingkat bathi miturut bathi resik|Rentabilitas dodolan miturut bathi resik ZYME (Zymeworks Corp)|Rentabilitas resik perusahaan TNGX|Margin dodolan resik IOVA (Iovance Biotherapeutics, Inc.)|Tingkat bathi resik IMTX|xencor.com - Margin dodolan resik|Margin resik Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Margin resik|Lyell Immunopharma - Tingkat bathi resik|IPHA (innate-pharma.com) - Margin dodolan resik|Margin dodolan resik pyxisoncology.com|Margin resik cgen.com (CGEN)|IOBT: Margin bathi resik|Sutro Biopharma Inc. - Rentabilitas dodolan miturut bathi resik|minktherapeutics.com (INKT) - Margin resik|HOWL: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Immix Biopharma IMMX|ALX Oncology (ALXO) - Margin resik|Margin resik Cue Biopharma, Inc. (CUE)|Margin resik PDS Biotechnology Corporation|Rentabilitas dodolan resik SONN (sonnetbio.com)|Margin dodolan resik MAIA|Margin dodolan perusahaan Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik LPTX|INTS - Margin resik|Margin dodolan perusahaan Sensei Biotherapeutics Inc SNSE|TOVX: Margin dodolan resik|Margin resik Gritstone Bio (GRTS)|KA (Kineta Corp) - Margin dodolan resik|Rentabilitas dodolan resik NEXI (NexImmune Corp)|Margin dodolan resik TSBX|VCNX (Vaccinex, Inc.) - Tingkat bathi resik|Margin dodolan resik HARP (Harpoon Therapeutics, Inc.)